Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $3.25 $4.50 Thursday, 9th May 2024 AVXL stock ended at $3.88. This is 4.58% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 9.32% from a day low at $3.60 to a day high of $3.93.
90 days $3.25 $6.15
52 weeks $3.25 $10.31

Historical Anavex Life Sciences Corp. prices

Date Open High Low Close Volume
Oct 20, 2016 $3.30 $3.36 $3.28 $3.36 288 500
Oct 19, 2016 $3.47 $3.47 $3.27 $3.32 510 600
Oct 18, 2016 $3.37 $3.40 $3.26 $3.37 382 500
Oct 17, 2016 $3.30 $3.32 $3.20 $3.29 371 700
Oct 14, 2016 $3.43 $3.43 $3.26 $3.32 546 900
Oct 13, 2016 $3.12 $3.53 $3.10 $3.42 1 544 700
Oct 12, 2016 $3.21 $3.26 $3.13 $3.17 540 700
Oct 11, 2016 $3.37 $3.37 $3.19 $3.23 646 100
Oct 10, 2016 $3.22 $3.40 $3.20 $3.39 736 400
Oct 07, 2016 $3.60 $3.61 $3.22 $3.25 1 561 200
Oct 06, 2016 $3.75 $3.80 $3.56 $3.59 1 272 300
Oct 05, 2016 $4.15 $4.28 $3.72 $3.77 4 654 400
Oct 04, 2016 $3.71 $3.71 $3.51 $3.67 913 600
Oct 03, 2016 $3.65 $3.72 $3.54 $3.63 857 400
Sep 30, 2016 $3.83 $3.89 $3.50 $3.63 1 542 400
Sep 29, 2016 $4.00 $4.00 $3.70 $3.75 3 359 500
Sep 28, 2016 $4.05 $4.88 $4.00 $4.13 27 094 300
Sep 27, 2016 $3.20 $3.21 $3.06 $3.14 843 000
Sep 26, 2016 $3.13 $3.19 $3.01 $3.15 1 069 000
Sep 23, 2016 $3.22 $3.24 $3.02 $3.11 2 105 100
Sep 22, 2016 $3.00 $3.54 $2.90 $3.28 11 301 900
Sep 21, 2016 $2.64 $2.66 $2.43 $2.61 653 000
Sep 20, 2016 $2.97 $2.97 $2.61 $2.64 761 800
Sep 19, 2016 $2.50 $2.60 $2.50 $2.60 366 100
Sep 16, 2016 $2.50 $2.56 $2.46 $2.51 377 400
Click to get the best stock tips daily for free!

About Anavex Life Sciences Corp.

Anavex Life Sciences . Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica... AVXL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT